Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell L...

od Xia Luo, Qiao Liu, Zhen Zhou, Lidan Yi, Liubao Peng, Xiaomin Wan, Xiaohui Zeng, Chongqing Tan, Sini Li
Izdano 2022-04-01